Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer-Reference-Cited by-同舟云学术

Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer

Published:2017-08-19 Issue:4 Volume:80 Page:777-785
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Danno Katsuki, ,Hata Taishi,Tamai Koki,Fujie Yujiro,Ide Yoshihito,Kim Ho Min,Ohnishi Tadashi,Morita Shunji,Yoshioka Shinichi,Kudo Toshihiro,Nishimura Junichi,Matsuda Chu,Akamatsu Hiroki,Mizushima Tsunekazu,Nezu Riichiro,Doki Yuichiro,Mori Masaki,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3419-1/fulltext.html

Reference25 articles.

1. Kidani Y, Inagaki K, Iigo M, Hoshi A, Kuretani K (1978) Antitumor activity of 1, 2-diaminocyclohexane–platinum complexes against sarcoma-180 ascites form. J Med Chem 21:1315–1318. doi: 10.1021/jm00210a029

2. Colvin H, Mizushima T, Eguchi H, Takiguchi S, Doki Y, Mori M (2017) Gastroenterological surgery in Japan: the past, the present and the future. Ann Gastroenterol Surg 1:5–10. doi: 10.1002/ags3.12008

3. NCCN clinical practice guideline: colon cancer. ver. 2 (2017). http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf . Accessed 3 Apr 2017

4. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, Van de Velde CJ, Balmana J, Regula J (2012) ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23:2479–2516. doi: 10.1093/annonc/mds236

5. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351. doi: 10.1056/NEJMoa032709

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of adjuvant XELOX in Japanese patients;2024-07-18

2. Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer;Oncology;2022

3. COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY;Siberian journal of oncology;2021-08-30

4. Is there an efficacy-effectiveness gap between randomized controlled trials and real-world studies in colorectal cancer: a systematic review and meta-analysis;Translational Cancer Research;2020-11

5. Prophylactic efficacy of ninjin’yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2);International Journal of Clinical Oncology;2020-03-30